Last Updated on: 31-12-2021

THSTI Bioassay Laboratory has completed more than 1,56,500 covid sample testing.

DBT-THSTI COVID-19 EFFORTS

Being an organization where infectious diseases has been one of the focus areas, our scientists have been watchful of emerging infectious diseases. Our work on those diseases that have been around for centuries, decades and some for years, on diagnostics, vaccines and drugs, has prepared us. The COVID-19 pandemic and its harbinger, SARS-CoV-2, but, has kept us on our toes. Having said that, we have gone all out with our efforts, with the support of our parent agency Department of Biotechnology (DBT) and our partnering agencies, in academia, hospitals and industry.

Research & Innovation

THSTI steps up Clinical & Translational research.

Read More

Testing

DBT-THSTI becomes an ICMR designated testing facility.

Read More

Science Outreach

Webinar series, Videos and Other resources.

Read More

For media queries write to

Dr. Soma Patnaik


(Professional Expert,Science Communication & PR)
scicom[at]thsti[dot]res[dot]in